Free Trial

DocuSign (NASDAQ:DOCU) Price Target Cut to $85.00 by Analysts at Wedbush

DocuSign logo with Computer and Technology background

DocuSign (NASDAQ:DOCU - Free Report) had its price objective reduced by Wedbush from $100.00 to $85.00 in a report issued on Thursday,Benzinga reports. They currently have a neutral rating on the stock.

A number of other analysts have also commented on DOCU. Citigroup reduced their target price on DocuSign from $115.00 to $110.00 and set a "buy" rating for the company in a report on Monday. Morgan Stanley decreased their target price on DocuSign from $92.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, June 6th. JPMorgan Chase & Co. dropped their price target on shares of DocuSign from $81.00 to $77.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. UBS Group cut their target price on DocuSign from $85.00 to $80.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Finally, Jefferies Financial Group reduced their price target on shares of DocuSign from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, March 31st. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, DocuSign presently has a consensus rating of "Hold" and an average target price of $88.77.

Get Our Latest Stock Analysis on DocuSign

DocuSign Trading Down 0.3%

NASDAQ DOCU traded down $0.23 during trading on Thursday, hitting $76.01. The company had a trading volume of 3,481,465 shares, compared to its average volume of 2,847,721. The company's fifty day moving average is $82.06 and its 200-day moving average is $86.15. DocuSign has a one year low of $48.80 and a one year high of $107.86. The company has a market cap of $15.39 billion, a price-to-earnings ratio of 15.67, a price-to-earnings-growth ratio of 6.94 and a beta of 1.14.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to analysts' expectations of $748.79 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. DocuSign's revenue was up 7.6% on a year-over-year basis. During the same period last year, the company posted $0.82 EPS. As a group, equities analysts anticipate that DocuSign will post 1.17 EPS for the current year.

DocuSign announced that its board has initiated a stock buyback program on Thursday, June 5th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to buy up to 6.6% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's management believes its shares are undervalued.

Insider Transactions at DocuSign

In other DocuSign news, insider James P. Shaughnessy sold 7,500 shares of the firm's stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total transaction of $609,825.00. Following the transaction, the insider now owns 45,875 shares of the company's stock, valued at approximately $3,730,096.25. This trade represents a 14.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the business's stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $76.09, for a total transaction of $608,720.00. Following the completion of the sale, the chief financial officer now owns 86,156 shares of the company's stock, valued at approximately $6,555,610.04. This represents a 8.50% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 47,851 shares of company stock worth $3,912,239. 1.01% of the stock is currently owned by insiders.

Hedge Funds Weigh In On DocuSign

A number of hedge funds and other institutional investors have recently modified their holdings of DOCU. Kestra Investment Management LLC purchased a new stake in DocuSign during the fourth quarter worth $30,000. Hemington Wealth Management increased its holdings in shares of DocuSign by 318.1% in the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after acquiring an additional 264 shares during the period. Banque Transatlantique SA bought a new position in shares of DocuSign in the 1st quarter worth $26,000. Golden State Wealth Management LLC lifted its stake in shares of DocuSign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after purchasing an additional 322 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its stake in shares of DocuSign by 102.6% during the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock worth $36,000 after purchasing an additional 201 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Analyst Recommendations for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines